DURHAM, N.C.--(BUSINESS WIRE)--Expression Analysis, the industry’s leading provider of Affymetrix GeneChip® brand microarray services for clinical trials, announced today an agreement with NuGEN Technologies, Inc. to offer genomic services using the WT-Ovation™ FFPE System. This whole transcriptome amplification solution is based on NuGEN’s proprietary Ribo-SPIA™ technology for gene expression profiling of small and degraded RNA samples derived from formalin-fixed, paraffin-embedded (FFPE) tissues. NuGEN has made the system available exclusively through Expression Analysis until the product is commercially launched.
